Home
  • English
  • Afrikaans (Afrikaans)
  • CONTACT US
  • +27 21 888 3000
  • info@remgro.com
MENUMENU
  • About
    Remgro
        • Our business
        • Group profile
        • Company history
        • Our business model
        • Understanding the business of Remgro
        • Key objectives and principal integrated risks
        • Leadership
        • Ethics hotline
  • Investor
    Centre
        • Salient features
        • Share statistics
        • Dividend history
        • Restructuring news
        • Share price information
        • Financial results and annual reports
        • SENS
        • Presentations
        • Calendar
        • IR contact
        • Listing Information
        • Shareholder information
        • Request an annual report
        • Events
  • Group
    Investments
        • Healthcare
        • Consumer products
        • Financial services
        • Infrastructure
        • Industrial
        • Diversified investment vehicles
        • Media
        • Portfolio investments
        • Social impact investments
        • Treasury and management services
  • ESG and
    sustainability
        • ESG and Sustainability Strategy Overview
        • Abridged Sustainability Report
        • Corporate Governance Report
        • Remuneration Report
        • Risk and Opportunities Management Report
        • Social and Ethics Committee Report
        • Corporate social investment
        • Charters and mandates
        • BBBEE Compliance Report
        • FTSE4Good Certificate
        • Our green head office
  • Media
    Centre
        • Media releases
        • Circulars
        • Media contact
        • Logo Library
        • Mediclinic offer

Calendar

Remgro Limited / Investor Centre / Calendar

Dates of importance to shareholders

Financial year-end 30 June
Annual General Meeting Wednesday, 30 November 2022
Financial reports
Announcement of interim results March
Interim report March
Announcement of annual results September
Annual Financial Statements September
Integrated Annual Report October
Dividends
Interim dividend
– declared March
– paid April
Final dividend
– declared September
– paid November
Final dividend No. 42
Ordinary dividend per share 100 cents
Last day to trade in order to participate in the dividend Tuesday, 8 November 2022
Shares trade ex dividend Wednesday, 9 November 2022
Record date Friday, 11 November 2022
Payment date Monday, 14 November 2022
Head Office
Millennia Park
16 Stellentia Avenue
Stellenbosch, 7600
+27 21 888 3000
info@remgro.com
  • CAREERS
  • GROUP SITES

ETHICS HOTLINE 0800 222 536


Invenfin is the venture and growth capital division of Remgro

VISIT THE SITE >

2023 © Remgro Limited

E-mail Disclaimer | Terms of Use | Privacy Policy | PAIA | Site Map

  • About
    Remgro
    ▼
    • Our business
    • Group profile
    • Company history
    • Our business model
    • Understanding the business of Remgro
    • Key objectives and principal integrated risks
    • Leadership
    • Ethics hotline
  • Investor
    Centre
    ▼
    • Salient features
    • Share statistics
    • Dividend history
    • Restructuring news
    • Share price information
    • Financial results and annual reports
    • SENS
    • Presentations
    • Calendar
    • IR contact
    • Listing Information
    • Shareholder information
    • Request an annual report
    • Events
  • Group
    Investments
    ▼
    • Financial services
    • Healthcare
    • Consumer products
    • Industrial
    • Infrastructure
    • Media
    • Diversified investment vehicles
    • Portfolio investments
    • Social impact investments
    • Treasury and management services
  • ESG and
    sustainability
    ▼
    • ESG and Sustainability Strategy Overview
    • Corporate Governance Report
    • Risk and Opportunities Management Report
    • Remuneration Report
    • Social and Ethics Committee Report
    • Abridged Sustainability Report
    • Corporate social investment
    • Charters and mandates
    • BBBEE Compliance Report
    • FTSE4Good Certificate
    • Our green head office
  • Media
    Centre
    ▼
    • Mediclinic offer
    • Media releases
    • Circulars
    • Media contact
    • Logo Library